Lanjuan Li
Impact in
- Biological Psychiatry top 0.05%
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria
Papers in
-
- Gut microbiota and health 151
- Epidemiology 270
- Liver Disease Diagnosis and Treatment 109
- Hepatitis B Virus Studies 83
- Influenza Virus Research Studies 47
- Co-authors
- Zongxin Ling (30 shared papers)Longxian Lv (51 shared papers)Kaijin Xu (53 shared papers)Hongcui Cao (103 shared papers)Chenxia Hu (22 shared papers)Baohong Wang (26 shared papers)Haifeng Lu (40 shared papers)Jifang Sheng (35 shared papers)
- Journals
- Scientific Reports (37 papers)PLoS ONE (25 papers)Frontiers in Microbiology (18 papers)BMC Infectious Diseases (14 papers)Nutrients (14 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lanjuan Li
875 papers receiving 39.5k citations
Lanjuan Li's Hit Papers
Peers
Comparison fields: 5 of 206
- Biological Psychiatry 1.6k
- Molecular Medicine 2.2k
- Hepatology 3.2k
- Infectious Diseases 6.8k
- Epidemiology 7.2k
Countries citing papers authored by Lanjuan Li
This map shows the geographic impact of Lanjuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanjuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanjuan Li more than expected).
Fields of papers citing papers by Lanjuan Li
This network shows the impact of papers produced by Lanjuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanjuan Li. The network helps show where Lanjuan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Lanjuan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 894 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Altered fecal microbiota composition in patients with major depressive disorder Hit paper breakdown → | 2015 | 1726 |
| 2 | Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series Hit paper breakdown → | 2020 | 1503 |
| 3 | Characterization of fecal microbial communities in patients with liver cirrhosis Hit paper breakdown → | 2011 | 808 |
| 4 | Molecular Architecture of the SARS-CoV-2 Virus Hit paper breakdown → | 2020 | 720 |
| 5 | The Human Microbiota in Health and Disease Hit paper breakdown → | 2017 | 609 |
| 6 | Tryptophan metabolism in health and disease Hit paper breakdown → | 2023 | 577 |
| 7 | Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent Hit paper breakdown → | 2009 | 568 |
| 8 | Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma Hit paper breakdown → | 2018 | 565 |
| 9 | Biodegradable nanostructures with selective lysis of microbial membranes Hit paper breakdown → | 2011 | 534 |
| 10 | Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort Hit paper breakdown → | 2019 | 492 |
| 11 | 2020 | 461 | |
| 12 | Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice Hit paper breakdown → | 2019 | 436 |
| 13 | The Intestinal Microbiota and Colorectal Cancer Hit paper breakdown → | 2020 | 386 |
| 14 | Progress in microencapsulation of probiotics: A review Hit paper breakdown → | 2020 | 381 |
| 15 | Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer Hit paper breakdown → | 2023 | 380 |
| 16 | 2010 | 363 | |
| 17 | Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial Hit paper breakdown → | 2020 | 345 |
| 18 | 2020 | 338 | |
| 19 | 2016 | 315 | |
| 20 | Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey Hit paper breakdown → | 2021 | 296 |
About Lanjuan Li
Lanjuan Li is a scholar working on Molecular Biology, Epidemiology, Hepatology, Infectious Diseases and Surgery, having authored 894 papers that have together received 40.0k indexed citations. Recurring topics across this work include Gut microbiota and health (151 papers), Liver Disease Diagnosis and Treatment (109 papers), Hepatitis B Virus Studies (83 papers), Clostridium difficile and Clostridium perfringens research (53 papers), Liver physiology and pathology (50 papers), Probiotics and Fermented Foods (48 papers), Influenza Virus Research Studies (47 papers) and Liver Disease and Transplantation (46 papers). The work is most often cited by research in Biological Psychiatry (1.6k citations), Molecular Medicine (2.2k citations), Hepatology (3.2k citations), Infectious Diseases (6.8k citations) and Epidemiology (7.2k citations). Lanjuan Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zongxin Ling, Longxian Lv, Kaijin Xu, Hongcui Cao, Chenxia Hu, Baohong Wang, Haifeng Lu, Jifang Sheng, Mingfei Yao and Bing Ruan. Their work appears in journals such as Scientific Reports, PLoS ONE, Frontiers in Microbiology, BMC Infectious Diseases and Nutrients.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.